New Bra-Like device could make breast cancer surgery more precise

NCT ID NCT04397185

Completed Symptom relief Sponsor: CairnSurgical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tested a new device called the Breast Cancer Locator (BCL), a custom plastic bra that helps surgeons find tumors during breast-conserving surgery. It was compared to the standard wire localization method in 480 women with non-palpable breast cancer. The goal was to see if the BCL could reduce the rate of positive margins (cancer cells at the edge of removed tissue) and the need for repeat surgeries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Breast Cancer Locator (BCL) device
What this could lead to: If successful, this device could make breast-conserving surgery more precise, reducing the need for repeat surgeries and improving cosmetic outcomes.
What could go wrong: This is a completed trial comparing a device to standard care, so results are already in. The device may not show significant improvement over wire localization, and benefits may vary by patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ductal breast carcinoma in situ female breast carcinoma invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER FEMALE

Contacts and locations

Locations

Arizona Center for Cancer Care

Scottsdale, Arizona, 85258, United States
Baptist MD Anderson Cancer Center

Jacksonville, Florida, 32207, United States
Basildon University Hospital

Basildon, United Kingdom
Catholic Medical Center

Manchester, New Hampshire, 03102, United States
Cheshire Medical Center

Keene, New Hampshire, 03431, United States
Columbia University Irving Medical Center and New York-Presbyterian Hospital

New York, New York, 10032, United States
Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03766, United States
Hennepin Healthcare

Minneapolis, Minnesota, 55415, United States
Inova Schar Cancer Institute

Fairfax, Virginia, 22031, United States
Kent Hospital

Warwick, Rhode Island, 02886, United States
LKH Feldkirch

Feldkirch, Austria
MD Anderson Cancer Center

Houston, Texas, 77030, United States
Manchester University NHS

Manchester, United Kingdom
Mass General/North Shore Center for Outpatient Care

Danvers, Massachusetts, 01923, United States
Moffitt Cancer Center

Tampa, Florida, 33612, United States
Princess Margaret Cancer Centre

Toronto, Ontario, M5G 2M9, Canada
Rutland Regional Medical Center

Rutland, Vermont, 05701, United States
St. Joseph Hospital

Nashua, New Hampshire, 03060, United States
St. Peter's Hospital

Albany, New York, 12208, United States
Steward Medical Group

Easton, Massachusetts, 02356, United States
Summit Health

Florham Park, New Jersey, 07932, United States
Tufts Medical Center

Boston, Massachusetts, 02111, United States
Women and Infants Hospital

Providence, Rhode Island, 02905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.